Merck KGaA, DiaSys Diagnostics Systems AG deal

MRK will sell its clinical chemistry business to DiaSys for an undisclosed sum in order to focus on its core business in chemicals. Effective Feb. 28 of next year, MRK's customers worldwide will recei...